(3beta,6alpha,9beta,16beta,20R,24S)-3-[(2,4-Di-O-acetyl-beta-D-xylopyranosyl)oxy]-16,25-dihydroxy-20,24-epoxy-9,19-cyclolanostan-6-yl beta-D-glucopyranoside(CAS: 84676-88-0)

This compound has a crystalline form with a molecular weight of approximately 1248.53 g/mol. It exhibits moderate solubility in organic solvents like methanol and acetone but is poorly soluble in water. Chemically, it shows reactivity towards nucleophiles due to the presence of the exo-epoxide ring and hydroxyl groups. It does not readily undergo acid or base-catalyzed hydrolysis but can be susceptible to enzymatic degradation.

This compound is synthesized through a multi-step process involving glycosylation reactions, acetylation, and epoxidation. Key steps include the formation of a xylopyranosyl derivative, subsequent coupling with a glucopyranosyl unit, followed by acetylation and epoxidation. The overall yield is moderate, around 55-65%, with high selectivity for the desired product.

This compound is primarily used in the pharmaceutical industry for its potential as a bioactive molecule. It can also find applications in the polymer industry for the development of specialized materials, and in the sensor and semiconductor industries for use in advanced analytical devices and electronic components.

Proper personal protective equipment (PPE) should be worn, including gloves, goggles, and lab coat. Work should be conducted in a fume hood to minimize inhalation risks. Spills should be cleaned up carefully with appropriate absorbent materials, and the area should be thoroughly cleaned. Always refer to the Safety Data Sheet (SDS) for specific guidance on handling and storage conditions.